Explore our articles

Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis

Dallas, TX (PRWEB) February 21, 2012 A Panamanian-led, multidisciplinary research team has published the first description of non-expanded…

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Therapeutic Effects of Intra-Arterial Delivery of Bone Marrow Stromal Cells in Traumatic Brain Injury of Rats—In Vivo Cell Tracking Study by Near-Infrared Fluorescence Imaging

Neurosurgery: February 2012 – Volume 70 – Issue 2 – p 435–444 doi: 10.1227/NEU.0b013e318230a795 Research-Animal Osanai, Toshiya MD,…

Ischemic Stroke Recovery May Be Improved Using Stem Cell Therapy

At the American Heart Association’s International Stroke Conference in New Orleans, two studies suggested that stem cell therapy…

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR,…

Fat Stem Cells Turn to Muscle: A Treatment for Muscular Dystrophy?

New research published in the journal Biomaterials by University of California, San Diego researcher Adam Engler suggests fat-derived…

Mechanism by Which Injured Tissue “Tells” Stem Cells to Leave Bone Marrow

Urao et al. Stem Cells. 2012 Jan 30. In addition to the established role of bone marrow derived…

Medistem Begins Phase II Clinical Trial for Heart Failure

Medistem Inc announced today treatment of 3 heart failure patients in the Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde…

Pluristem to develop stem cell therapy on its own: CEO

Anand Basu, Reuters Pluristem is an Israeli company that is publicly traded on NASDAQ and has been working…